Mikart and Fluid Pharma Ltd have entered into a collaboration agreement to manufacture clinical trial materials using proprietary MicroCoat™ technology to advance new therapies
yahoo.com
news
2022-10-19 15:45:00

ATLANTA and HERTFORDSHIRE, England, Oct. 19, 2022 /PRNewswire/ -- Mikart, LLC ("Mikart") a comprehensive contract development and manufacturing organization announced that it has entered into a collaboration agreement with Fluid Pharma Ltd, a technology licensing company, to advance the application of Fluid Pharma's proprietary MicroCoat™ technology in new therapies for pediatric, geriatric, and oral liquid modified release applications, in North America.

Mikart a recognized CDMO in formulation development, contract manufacturing and packaging.
